Evidence map›Paper›PMID 30601833›Full record

ArticlePloS one2019

Improved access to early diagnosis and complete treatment of malaria in Odisha, India.

Sreya Pradhan, Madan Mohan Pradhan, Ambarish Dutta, Naman K Shah, Pyare Lal Joshi, Khageshwar Pradhan, S K Sharma, Penny Grewal Daumerie, Jaya Banerji, Stephan Duparc and 4 more

Abstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Sreya PradhanNational Vector Borne Disease Control Programme, Government of Odisha, Bhubaneswar, India.
Madan Mohan PradhanNational Vector Borne Disease Control Programme, Government of Odisha, Bhubaneswar, India.
Ambarish DuttaIndian Institute of Public Health, Bhubaneswar, India.
Naman K ShahUniversity of North Carolina, Chapel Hill, North Carolina, United States of America.
Pyare Lal JoshiIndependent Malariologist, New Delhi, India.
Khageshwar PradhanNational Institute of Malaria Research Field Unit, Rourkela, India.
S K SharmaNational Institute of Malaria Research, New Delhi, India.
Penny Grewal DaumerieMedicines for Malaria Venture, Geneva, Switzerland.
Jaya BanerjiMedicines for Malaria Venture, Geneva, Switzerland.
Stephan DuparcMedicines for Malaria Venture, Geneva, Switzerland.
Kamini MendisIndependent Malariologist, Colombo, Sri Lanka.
Shiva MurugasampillayGlobal Public Health, Geneva, Switzerland.
Neena ValechaNational Institute of Malaria Research, New Delhi, India.
Anupkumar R AnvikarNational Institute of Malaria Research, New Delhi, India.ORCID 0000-0001-8455-6054

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn 2013, the Comprehensive Case Management Programme (CCMP) was initiated to assess the impact of universal access to diagnosis and treatment and improved surveillance on malaria transmission in different settings in Odisha state, India.

methodsPairs of intervention and control sub-districts (blocks), matched on malaria incidence were selected in four districts with different transmission intensities. CCMP activities included training and supervision, ensuring no stock-outs of malaria tests and drugs, analysing verified surveillance data, stratifying areas based on risk factors, and appointing alternative providers to underserved areas. Composite risk scores were calculated for each sub-centre using principal component analysis. Post-pre changes (2013-2015 versus 2011-2012) for annual blood examination rates (ABER) and annual parasite incidence (API) across intervention and control groups were assessed using difference-in-difference (DID) estimates, adjusted for malaria transmission risk.

resultsIn the intervention sub-centres, the mean increase in ABER was 6.41 tests/sub-centre (95%CI 4.69, 8.14; p<0.01) and in API was 9.2 cases diagnosed/sub-centre (95%CI 5.18, 13.21; p<0.01). The control sub-centres reported lower increases in ABER (2.84 [95%CI 0.35, 5.34]; p<0.05) and API (3.68 [95%CI 0.45, 6.90]; p<0.05). The control-adjusted post-pre changes in API showed that 5.52 more cases (95%CI 0.34, 10.70; p<0.05) were diagnosed, and a 3.6 more cases (95%CI 0.58, 6.56; p<0.05) were tested per sub-centre in the intervention versus control areas. Larger differences in post-pre changes in API between intervention and control sub-centres were registered in the higher transmission-risk areas compared with the lower risk areas. All the changes were statistically significant.

conclusionsIntensive intervention activities targeted at improved access to malaria diagnosis and treatment produced a substantial increase in blood examination and case notification, especially in inaccessible, hard-to-reach pockets. CCMP provides insights into how to achieve universal coverage of malaria services through a routine, state-run programme.

Indexed as

HumansIncidenceIndiaMalariaPrincipal Component AnalysisRisk Factors

Identifiers

PMID30601833
PMCPMC6314604

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.